COMPASS THERAPEUTICS, INC. General and Administrative Expense
COMPASS THERAPEUTICS, INC. (CMPX) reported General and Administrative Expense of $7.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. general and administrative expense for the quarter ending 2026-06-30 was $7.40M, a 59.17% increase year-over-year.
- COMPASS THERAPEUTICS, INC. general and administrative expense for the quarter ending 2026-03-31 was $6.91M, a 40.66% increase year-over-year.
- COMPASS THERAPEUTICS, INC. general and administrative expense for the quarter ending 2025-12-31 was $4.32M, a 22.12% increase year-over-year.
- COMPASS THERAPEUTICS, INC. general and administrative expense for the quarter ending 2025-09-30 was $2.99M, a 17.54% decline year-over-year.
- COMPASS THERAPEUTICS, INC. general and administrative expense for fiscal 2025 was $16.87M, a 11.48% increase from fiscal 2024.
- COMPASS THERAPEUTICS, INC. general and administrative expense for fiscal 2024 was $15.13M, a 23.61% increase from fiscal 2023.
- COMPASS THERAPEUTICS, INC. general and administrative expense for fiscal 2023 was $12.24M, a 5.02% increase from fiscal 2022.
- COMPASS THERAPEUTICS, INC. general and administrative expense for fiscal 2022 was $11.66M, a 6.69% increase from fiscal 2021.
| Period end | General and Administrative Expense 0 month | General and Administrative Expense 3 month | General and Administrative Expense 3 month as first filed | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7.40M 10-Q · filed 2026-08-06 | $14.31M 10-Q · filed 2026-08-06 | $18.63M derived: sum of 3 quarters · filed 2026-08-06 | $21.62M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $6.91M 10-Q · filed 2026-05-05 | $11.23M derived: sum of 2 quarters · filed 2026-05-05 | $14.22M derived: sum of 3 quarters · filed 2026-05-05 | $18.87M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.31M derived: sum of 2 quarters · filed 2026-03-05 | $11.96M derived: sum of 3 quarters · filed 2026-08-06 | $16.87M 10-K · filed 2026-03-05 | ||
| 2025-09-30 | $2.99M 10-Q · filed 2025-11-05 | $7.64M derived: sum of 2 quarters · filed 2026-08-06 | $12.55M 10-Q · filed 2025-11-05 | $16.09M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $4.65M 10-Q · filed 2026-08-06 | $9.56M 10-Q · filed 2026-08-06 | $13.10M derived: sum of 3 quarters · filed 2026-08-06 | $16.73M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $4.91M 10-Q · filed 2026-05-05 | $8.45M derived: sum of 2 quarters · filed 2026-05-05 | $12.07M derived: sum of 3 quarters · filed 2026-05-05 | $16.80M derived: sum of 4 quarters · filed 2026-05-05 | ||
| 2024-12-31 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.16M derived: sum of 2 quarters · filed 2026-03-05 | $11.88M derived: sum of 3 quarters · filed 2026-03-05 | $15.13M 10-K · filed 2026-03-05 | ||
| 2024-09-30 | $3.63M 10-Q · filed 2025-11-05 | $8.35M derived: sum of 2 quarters · filed 2025-11-05 | $11.60M 10-Q · filed 2025-11-05 | $14.56M derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | $4.72M 10-Q · filed 2025-08-11 | $7.97M 10-Q · filed 2025-08-11 | $10.94M derived: sum of 3 quarters · filed 2025-08-11 | $14.03M derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | $3.25M 10-Q · filed 2025-05-08 | $6.21M derived: sum of 2 quarters · filed 2025-05-08 | $9.31M derived: sum of 3 quarters · filed 2025-05-08 | $12.42M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $6.06M derived: sum of 2 quarters · filed 2025-02-27 | $9.18M derived: sum of 3 quarters · filed 2025-02-27 | $12.24M 10-K · filed 2025-02-27 | ||
| 2023-09-30 | $3.10M 10-Q · filed 2024-11-12 | $6.21M derived: sum of 2 quarters · filed 2024-11-12 | $9.28M 10-Q · filed 2024-11-12 | $12.24M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $3.11M 10-Q · filed 2024-08-12 | $6.18M 10-Q · filed 2024-08-12 | $9.15M derived: sum of 3 quarters · filed 2024-08-12 | $11.95M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $3.07M 10-Q · filed 2024-05-13 | $6.03M derived: sum of 2 quarters · filed 2024-05-13 | $8.84M derived: sum of 3 quarters · filed 2024-05-13 | $11.96M derived: sum of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $5.77M derived: sum of 2 quarters · filed 2024-03-21 | $8.89M derived: sum of 3 quarters · filed 2024-03-21 | $11.66M 10-K · filed 2024-03-21 | ||
| 2022-09-30 | $2.81M 10-Q · filed 2023-11-09 | $5.93M derived: sum of 2 quarters · filed 2023-11-09 | $8.70M 10-Q · filed 2023-11-09 | $12.13M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $3.13M 10-Q · filed 2023-08-03 | $5.89M 10-Q · filed 2023-08-03 | $9.32M derived: sum of 3 quarters · filed 2023-08-03 | $12.02M derived: sum of 4 quarters · filed 2023-08-03 | ||
| 2022-03-31 | $2.77M 10-Q · filed 2023-05-04 | $6.19M derived: sum of 2 quarters · filed 2023-05-04 | $8.89M derived: sum of 3 quarters · filed 2023-05-04 | $11.06M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $6.13M derived: sum of 2 quarters · filed 2023-03-15 | $8.29M derived: sum of 3 quarters · filed 2023-03-15 | $10.93M 10-K · filed 2023-03-15 | ||
| 2021-09-30 | $2.70M 10-Q · filed 2022-11-09 | $4.87M derived: sum of 2 quarters · filed 2022-11-09 | $7.50M 10-Q · filed 2022-11-09 | $11.04M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $2.17M 10-Q · filed 2022-08-01 | $4.80M 10-Q · filed 2022-08-01 | $8.35M derived: sum of 3 quarters · filed 2022-08-01 | $13.64M derived: sum of 4 quarters · filed 2022-08-01 | ||
| 2021-03-31 | $2.63M 10-Q · filed 2022-05-09 | $6.18M derived: sum of 2 quarters · filed 2022-05-09 | $11.47M derived: sum of 3 quarters · filed 2022-05-09 | $13.55M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $8.84M derived: sum of 2 quarters · filed 2022-03-18 | $10.92M derived: sum of 3 quarters · filed 2022-03-18 | $12.91M 10-K · filed 2022-03-18 | ||
| 2020-09-30 | $5.29M 10-Q · filed 2021-11-12 | $7.38M derived: sum of 2 quarters · filed 2021-11-12 | $9.36M 10-Q · filed 2021-11-12 | $9.65M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $2.08M 10-Q · filed 2021-08-16 | $4.34M 10-Q · filed 2021-08-16 | $4.36M derived: sum of 3 quarters · filed 2021-08-16 | $6.76M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $2.26M 10-Q · filed 2021-04-30 | $2.27M derived: sum of 2 quarters · filed 2021-04-30 | $4.67M derived: sum of 3 quarters · filed 2021-04-30 | $32.10K 10-K · filed 2020-06-08 | ||
| 2019-12-31 | $10.24K 10-Q · filed 2020-02-14 | $2.41M derived: sum of 2 quarters · filed 2020-11-09 | $27.71K 10-Q · filed 2020-02-14 | $11.60M 10-K · filed 2021-03-05 | ||
| 2019-09-30 | $2.40M 10-Q · filed 2020-11-09 | $7.15K 10-Q · filed 2019-11-13 | $17.47K 10-Q · filed 2019-11-13 | $8.50M 10-Q · filed 2020-11-09 | $5.71M derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $3.28M 10-Q · filed 2020-08-13 | $10.32K 10-Q · filed 2019-08-13 | $6.63M 10-Q · filed 2020-08-13 | $3.30M derived: sum of 3 quarters · filed 2020-08-13 | $3.31M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $7.81K derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-08 | $17.08K derived: sum of 2 quarters · filed 2020-06-08 | $24.86K derived: sum of 3 quarters · filed 2020-06-08 | $32.76K 10-K · filed 2020-06-08 | ||
| 2018-12-31 | $9.27K 10-Q · filed 2020-02-14 | $17.05K derived: sum of 2 quarters · filed 2020-02-14 | $24.95K 10-Q · filed 2020-02-14 | |||
| 2018-09-30 | $7.79K 10-Q · filed 2019-11-13 | $15.68K 10-Q · filed 2019-11-13 | ||||
| 2018-06-30 | $7.89K 10-Q · filed 2019-08-13 | |||||
| 2018-03-31 | $35.00K 10-K · filed 2019-07-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |